OTCMKTS:RCDTF Recordati Industria Chimica e Farmaceutica (RCDTF) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free RCDTF Stock Alerts $51.60 0.00 (0.00%) (As of 04/22/2024 ET) Add Compare Share Share Today's Range$51.60▼$51.6050-Day Range$51.60▼$51.6052-Week Range$51.60▼$51.98VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E Ratio26.74Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsShort InterestStock AnalysisAnalyst ForecastsChartEarningsShort Interest Get Recordati Industria Chimica e Farmaceutica alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About Recordati Industria Chimica e Farmaceutica Stock (OTCMKTS:RCDTF)Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis. The company also develops CARBAGLU for hyperammonemia due to NAGS deficiency; QARZIBA, an apeiron for the treatment of high-risk neuroblastoma patients with a partial response at the chemotherapeutical through myeloablative therapy and stem cell transplantation, and relapsed or refractory neuroblastoma. In addition, it offers SYLVANT for the treatment of idiopathic multicentric Castleman diseases; REAGILA for Schizophrenia; and ELIGARD for hormone-dependent prostate cancer, as well as CAPHOSOL, a medical device for treatment of oral mucositis due to chemo and radiation therapy. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.Read More RCDTF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RCDTF Stock News HeadlinesMarch 19, 2024 | msn.comFarmaceutica, le big si muovono: Astrazeneca acquista, Pfizer vende. Da Recordati cedola maggiorata con un occhio alle opportunitàDecember 29, 2023 | msn.comBorsa Milano, lieve rialzo (+0,07%), Recordati e banche in rialzoApril 23, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.December 19, 2023 | seekingalpha.comRICFY Recordati Industria Chimica e Farmaceutica S.p.A.November 7, 2023 | msn.comItaly's Recordati sees 2023 results at top end of the rangeNovember 7, 2023 | uk.news.yahoo.comItaly's Recordati nudges up 2023 guidance as 9-mth revenue, profit jumpsSeptember 9, 2023 | forbes.comFondo pensione: cos’è e come funzionaJuly 21, 2023 | msn.comBorsa: Milano positiva con le banche, vola RecordatiApril 23, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.May 12, 2023 | msn.comItaly's Recordati boosted by strong sales in RussiaMay 11, 2023 | msn.comRecordati GAAP EPS of €0.59, revenue of €551.4MMay 11, 2023 | msn.comRecordati ups guidance on strong growth in specialty, primary care marketsApril 21, 2023 | msn.comRecordati, nel primo trimestre ricavi per 551,4 milioni di euro (+31,5%). Ok dei soci al buy back da massimi 200 milioniFebruary 21, 2023 | reuters.comRecordati shares fall after core profit margin forecasts disappointFebruary 17, 2023 | msn.comRecordati bocciata da Barclays. Che taglia il prezzo obiettivo da 40 a 35 euroJanuary 23, 2023 | reuters.comRECItah.MIJanuary 14, 2023 | businesswire.comCresce l'espansione di AESARA Europe con la nomina di Patrizia Berto, una veterana dell'industria farmaceutica italianaNovember 8, 2022 | msn.comRecordati alza la guidance per il 2022. Acconto del dividendo pari a 0,55 euroOctober 28, 2022 | finanznachrichten.deSherwin-Williams To Buy Italian Wood Coatings Firm Industria Chimica AdriaticaSeptember 27, 2022 | finance.yahoo.comRecordati Industria Chimica e Farmaceutica S.p.A. (0KBS.L)September 18, 2022 | finance.yahoo.comRecordati Industria Chimica e Farmaceutica S.p.A. (REC.VI)September 8, 2022 | finance.yahoo.comRecordati Industria Chimica e Farmaceutica S.p.A. (REC.MI)August 31, 2022 | finance.yahoo.comRecordati Rare Diseases Announce Publication of Long-term Outcomes From the Extension to the Phase III LINC 3 Study of Isturisa® (Osilodrostat) in Patients With Cushing’s Disease in the European Journal of EndocrinologyJuly 30, 2022 | seekingalpha.comRecordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Robert Koremans on Q2 2022 Results - Earnings Call TranscriptJune 16, 2022 | apnews.comRecordati Rare Diseases Announces Positive Data From Phase III Linc 4, Phase III Linc 3, and Illustrate ISTURISA® Studies Presented at ENDO 2022June 8, 2022 | finance.yahoo.comRecordati Rare Diseases Announces Several Scientific Abstracts to Be Presented at the Upcoming Endo Society Annual MeetingMay 14, 2022 | seekingalpha.comRecordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Robert Koremans on Q1 2022 Results - Earnings Call TranscriptSee More Headlines Receive RCDTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Recordati Industria Chimica e Farmaceutica and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private households Sub-IndustryN/A Current SymbolOTCMKTS:RCDTF Previous SymbolNASDAQ:RCDTF CUSIPN/A CIKN/A Webwww.recordati.com Phone390-248-7871Fax39-02-4007-3747Employees4,369Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$1.93 Trailing P/E Ratio26.74 Forward P/E RatioN/A P/E GrowthN/ANet Income$329.08 million Net Margins18.51% Pretax MarginN/A Return on Equity31.80% Return on Assets12.83% Debt Debt-to-Equity Ratio0.80 Current Ratio1.28 Quick Ratio0.86 Sales & Book Value Annual Sales$1.95 billion Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$7.90 per share Price / Book6.53Miscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta0.32 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesDr. Robert Koremans M.D. (Age 62)CEO & Director Comp: $1.96MMr. Luigi Felice La Corte (Age 55)Group CFO & Executive Director Comp: $1.03MMs. Cathrin Petty (Age 51)Executive Director Mr. Giampiero Mazza (Age 55)Executive Director Mr. Giorgio De Palma (Age 50)Executive Director Ms. Eugenia LitzVP & Head of Investor RelationsMs. Bibianne BonGroup Chief Legal OfficerMs. Laura ContiGroup Communications DirectorMr. Gabriele FinziExecutive VP of Corporate Development, Licensing & InnovationMr. Roberto TeruzziExecutive Vice President of Group Industrial OperationsMore ExecutivesKey CompetitorsMDxHealthNASDAQ:MDXHPharma MarOTCMKTS:PHMMFRespiriOTCMKTS:KMLXF180 Life SciencesNASDAQ:ATNFW1933 IndustriesOTCMKTS:TGIFFView All Competitors RCDTF Stock Analysis - Frequently Asked Questions Should I buy or sell Recordati Industria Chimica e Farmaceutica stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Recordati Industria Chimica e Farmaceutica in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" RCDTF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RCDTF, but not buy additional shares or sell existing shares. View RCDTF analyst ratings or view top-rated stocks. How have RCDTF shares performed in 2024? Recordati Industria Chimica e Farmaceutica's stock was trading at $46.00 on January 1st, 2024. Since then, RCDTF stock has increased by 12.2% and is now trading at $51.60. View the best growth stocks for 2024 here. Are investors shorting Recordati Industria Chimica e Farmaceutica? Recordati Industria Chimica e Farmaceutica saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 524,500 shares, an increase of 99.1% from the March 15th total of 263,500 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 5,245.0 days. View Recordati Industria Chimica e Farmaceutica's Short Interest. How do I buy shares of Recordati Industria Chimica e Farmaceutica? Shares of RCDTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:RCDTF) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Recordati Industria Chimica e Farmaceutica S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.